Shaking creates violent physical forces inside the vial that tear apart the peptide structure
Thus, it was likely that after tail amputation in rats, with/out heparin and warfarin administration, BPC 157 would counteract the consequences of administration of the NOS-blocker, L-NAME (i.e., prothrombotic effect and thereby thrombocytopenia) and/or NOS-substrate, L-arginine (i.e., antithrombotic effect and thereby more bleeding) [2931]
No, it is based on preclinical evidence and user practice rather than human clinical trials
You just look and feel healthier
The single principle that makes every calculation below work is this: concentration is drug divided by water
Treatment of acute sciatica with transforaminal epidural corticosteroids and local anesthetic: design of a randomized controlled trial